-
Publication Venue For
-
N-of-1 Clinical Trials.
7:630-631.
2019
-
Reframing Global Variation in Heart Failure Trials: Thinking Beyond Location on the Map..
7:347-349.
2019
-
Sex-Related Differences in Use and Outcomes of Left Ventricular Assist Devices as Bridge to Transplantation..
7:250-257.
2019
-
NT-proBNP Goal Achievement Is Associated With Significant Reverse Remodeling and Improved Clinical Outcomes in HFrEF..
7:158-168.
2019
-
Adiposity and Incident Heart Failure and its Subtypes.
6:999-1007.
2018
-
Aortic Insufficiency During Contemporary Left Ventricular Assist Device Support: Analysis of the INTERMACS Registry..
6:951-960.
2018
-
Is it Time to Get More Aggressive With Aortic Valve Insufficiency During LVAD Implantation?.
6:961-963.
2018
-
Depression in Heart Failure: Beyond a SADHART.
6:885-886.
2018
-
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine: The ROPA-DOP Trial.
6:859-870.
2018
-
Politically Correct Heart Failure Research in America to Avoid Geographic Variation.
6:805-806.
2018
-
Predicting Prognosis in Heart Failure: Important, But Easier Said Than Done ∗.
6:754-756.
2018
-
HFpEF: From Early Observations to Worldwide Awareness.
6:718-719.
2018
-
Cardiovascular Drug Pricing: Less Innovation for More Access?.
6:613-614.
2018
-
Will Biomarkers Succeed as a Surrogate Endpoint in Heart Failure Trials? ∗.
6:570-572.
2018
-
Dying With Dignity and Heart Failure: A Lesson From Barbara Bush.
6:536-537.
2018
-
What's One More Day?.
6:438.
2018
-
Changing the Research Culture in the United States.
6:344-345.
2018
-
Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey.
6:273-285.
2018
-
Heart Failure Health Care 2018: Challenges and Opportunities.
6:262-263.
2018
-
Reply: Efficacy of Subcutaneous vs. Intravenous Administration of Furosemide in Patients With Worsening Heart Failure: The Devil Is in the Details.
6:267-208.
2018
-
Smartphone, Mom, and HFpEF.
6:176.
2018
-
Efficacy of Intravenous Furosemide Versus a Novel, pH-Neutral Furosemide Formulation Administered Subcutaneously in Outpatients With Worsening Heart Failure.
6:65-70.
2018
-
I Don't Care How Low My BNP Is, I Want to Feel Good.
6:82-83.
2018
-
Medical Management of Patients With a Left Ventricular Assist Device for the Non-Left Ventricular Assist Device Specialist.
5:622-631.
2017
-
Can Vaccinations Improve Heart Failure Outcomes? Contemporary Data and Future Directions.
5:195-203.
2017
-
Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes Findings From the ASCEND-HF Trial.
5:3-13.
2017
-
Effects of Left Ventricular Assist Device Support on Biomarkers of Cardiovascular Stress, Fibrosis, Fluid Homeostasis, Inflammation, and Renal Injury.
3:30-39.
2015
-
Mineralocorticoid receptor antagonists modulate galectin-3 and interleukin-33/ST2 signaling in left ventricular systolic dysfunction after acute myocardial infarction..
3:50-58.
2015
-
BAG3 protein in advanced-stage heart failure..
2:673-675.
2014
-
Editorial Mentorship.
2:321-322.
2014
-
The prognostic significance of heart rate in patients hospitalized for heart failure with reduced ejection fraction in sinus rhythm: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study With Tolvaptan) trial..
1:488-496.
2013
-
Left bundle branch block predicts better survival in women than men receiving cardiac resynchronization therapy: long-term follow-up of ∼ 145,000 patients..
1:237-244.
2013